Sharecafe

Antisense Therapeutics (ASX: ANP) – Webinar Presentation

Mark Diamond - Managing Director and CEO -  Antisense Therapeutics is a biotechnology company, developing and commercializing antisense pharmaceuticals for large unmet markets in rare diseases.

Mark Diamond – Managing Director and CEO –  Antisense Therapeutics is a biotechnology company, developing and commercializing antisense pharmaceuticals for large unmet markets in rare diseases.

Serving up fresh finance news, marker movers & expertise.
LinkedIn
Email
X

All Categories

Subscribe

get the latest